Genomic Profile, Radiological and Clinical Features of IDH Wild-Type WHO Grades II and III Glioma

被引：0
|
作者：
Lin, Xuling [1 ]
Brennan, Cameron [1 ]
Zehir, Ahmet [1 ]
Berger, Michael [1 ]
Solit, David [1 ]
Hyman, David [1 ]
Rosenblum, Marc [1 ]
Huse, Jason [1 ]
Omuro, Antonio [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.254
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Stratification of IDH wild-type WHO grade II / III gliomas by molecular marker
    Kuwahara, Kiyonori
    Ohba, Shigeru
    Nakae, Shunsuke
    Hattori, Natsuki
    Sasaki, Hikaru
    Abe, Masato
    Hasegawa, Mitsuhiro
    Hirose, Yuichi
    BRAIN PATHOLOGY, 2019, 29 : 151 - 151
  • [2] GENETIC VARIATION BETWEEN IDH MUTANT AND IDH WILD-TYPE GLIOMA
    Li, Shaoqun
    Lai, Mingyao
    Zhou, Jiangfen
    Zhen, Junjie
    Cai, Linbo
    NEURO-ONCOLOGY, 2021, 23 : 119 - 119
  • [3] Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning
    Suchorska, Bogdana
    Schueller, Ulrich
    Biczok, Annamaria
    Lenski, Markus
    Albert, Nathalie L.
    Giese, Armin
    Kreth, Friedrich-Wilhelm
    Ertl-Wagner, Birgit
    Tonn, Joerg-Christian
    Ingrisch, Michael
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 15 - 27
  • [4] Clinical, radiologic & prognostic profile of IDH wild type diffuse astrocytic glioma with molecular features of glioblastoma.
    Akintola, Oluwatosin
    Samore, Wesley
    Alvarez, Maria Martinez-Lage
    Gerstner, Elizabeth Robins
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas
    Mikkelsen, Vilde Elisabeth
    Dai, Hong Yan
    Stensjoen, Anne Line
    Berntsen, Erik Magnus
    Salvesen, Oyvind
    Solheim, Ole
    Torp, Sverre Helge
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (08): : 855 - 862
  • [6] A RETROSPECTIVE STUDY OF TREATMENT STRATEGIES AND OUTCOMES IN WHO GRADE II AND III ISOCITRATE DEHYDROGENASE (IDH) WILD-TYPE ASTROCYTOMA
    Aaroe, Ashley
    Dono, Antonio
    Youssef, Michael
    Alfaro-Munoz, Kristin
    Weathers, Shiao-Pei
    O'Brien, Barbara
    Majd, Nazanin
    Harrison, Rebecca
    Loghin, Monica
    Soomro, Zaid
    Williford, Garret
    Fuller, Gregory
    Yung, W. K. Alfred
    Yeboa, Debra
    Esquenazi, Yoshua
    Ballester, Leomar Y.
    de Groot, John
    Kamiya-Matsuoka, Carlos
    NEURO-ONCOLOGY, 2020, 22 : 164 - 165
  • [7] TUMOR IMMUNOSUPPRESSION IS TIGHTLY COUPLED WITH IDH WILD-TYPE IN GLIOMA PATIENTS
    Mu, Luyan
    Yang, Changlin
    Gu, Yunhe
    Ge, Haitao
    Chang, Yifan
    De Leon, Gabriel
    Sayour, Elias
    Xia, Songsong
    Bao, Hongbo
    Yu, Long
    Jin, Linchun
    Qi, Jiping
    Sun, Jiahang
    Gao, Xiang
    Song, Ying Ching
    Kubilis, Paul
    Mitchell, Duane
    Lin, Zhiguo
    Huang, Jianping
    NEURO-ONCOLOGY, 2016, 18 : 91 - 91
  • [8] Matching Quantitative MRI Parameters with Histological Features of Treatment-Naive IDH Wild-Type Glioma
    Maurer, Gabriele D.
    Tichy, Julia
    Harter, Patrick N.
    Noeth, Ulrike
    Weise, Lutz
    Quick-Weller, Johanna
    Deichmann, Ralf
    Steinbach, Joachim P.
    Baehr, Oliver
    Hattingen, Elke
    CANCERS, 2021, 13 (16)
  • [9] Analyses of metastasis-associated genes in IDH wild-type glioma
    Li, Xiaozhi
    Meng, Yutong
    BMC CANCER, 2020, 20 (01)
  • [10] Analyses of metastasis-associated genes in IDH wild-type glioma
    Xiaozhi Li
    Yutong Meng
    BMC Cancer, 20
12345